Structure, Functional Domains and Subcellular Distribution of Glucocorticoid Receptor

  • Jan Carlstedt-Duke
  • Ann-Charlotte Wikstrom
  • Jan-Ake Gustafsson
Part of the Serono Symposia, USA book series (SERONOSYMP)


Much interest has been focused on the steroid hormone receptor proteins during recent years. These proteins are transcriptional regulatory factors and have proven to be of central interest for research on gene regulation in eukaryotic cells. It was hypothesized early that the steroid hormones exerted their biological effects via the genome with the help of soluble receptor proteins (1), and this model, with minor modifications, holds true today, even with the more detailed information available. Our interest has focused on the glucocorticoid receptor protein (GR) and its mechanism of action. We have worked predominantly with the rat liver GR, although some work on the mouse and human GR has also been carried out at our laboratory. There are only minor differences between species. The structure and function of GR will be discussed in this chapter.


Glucocorticoid Receptor Limited Proteolysis Progestin Receptor Mouse Lymphoma Cell Human Glucocorticoid Receptor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Baxter JD, Tomkins GH. Specific cytoplasmic glucocorticoid hormone receptors in hepatoma tissue culture cells. Proc Natl Acad Sci USA 1971; 68: 932–7.PubMedCrossRefGoogle Scholar
  2. 2.
    King WJ, Greene GL. Monoclonal antibodies localize oestrogen receptor in the nucleus of target cells. Nature 1984; 307: 745–7.PubMedCrossRefGoogle Scholar
  3. 3.
    King WJ, DeSombre ER, Jensen EV, Greene GL. Comparison of immunocytochemical and steroid-binding assays for estrogen receptor in human breast tumors. Cancer Res 1985; 45: 293–304.PubMedGoogle Scholar
  4. 4.
    Press MF, Nousek-Goebl NA, Greene GL. Immunoelectron microscopic localization of estrogen receptor with monoclonal estrophilin antibodies. J Histochem Cytochem 1985; 33: 915–24.PubMedCrossRefGoogle Scholar
  5. 5.
    Perrot-Applanat M, Logeat F, Groyer-Picard MT, Milgrom E. Immunocytochemical study of mammalian progesterone receptor using monoclonal antibodies. Endocrinology 1985; 116: 1473–84.PubMedCrossRefGoogle Scholar
  6. 6.
    Welshons WV, Lieberman ME, Gorski J. Nuclear localization of unoccupied oestrogen receptors. Nature 1984; 307: 747–9.PubMedCrossRefGoogle Scholar
  7. 7.
    Welshons WV, Krummel BM, Gorski J. Nuclear localization of unoccupied receptors for glucocorticoids, estrogens and progesterone in GH cells. Endocrinology 1985; 117: 2140–7.PubMedCrossRefGoogle Scholar
  8. 8.
    Govindan MV. Immunofluorescence microscopy of the intracellular translocation of glucocorticoid-receptor complexes in rat hepatoma (HTC) cells. Exp Cell Res 1980; 127: 293–7.PubMedCrossRefGoogle Scholar
  9. 9.
    Papamichail M, Tsokos G, Tsawdaroglou N, Sekeris CE. Immunocytochemical demonstration of glucocorticoid receptors in different cell types and their translocation from the cytoplasm to the cell nucleus in the presence of dexamethasone. Exp Cell Res 1980; 125: 490–3.PubMedCrossRefGoogle Scholar
  10. 10.
    Gustafsson J-A, Carlstedt-Duke J, Fuxe K, Carlstrom K, Okret S, Wrange O. Studies on the glucocorticoid receptor. In: Fuxe F, Wetterberg L, Gustafsson J-A, eds. Steroid hormone regulation of the brain. Oxford: Pergamon Press, 1981: 31–9.Google Scholar
  11. 11.
    Bernard PA, Joh TH. Characterization and immunocytochemical demonstration of glucocorticoíd receptor using antisera specific to transformed receptor. Arch Biochem Biophys 1984; 229: 466–76.PubMedCrossRefGoogle Scholar
  12. 12.
    Antakly T, Eisen HJ. Immunocytochemical localization of glucocorticoid receptor in target cells. Endocrinology 1984; 115: 1984–9.PubMedCrossRefGoogle Scholar
  13. 13.
    Fuxe K, Wikstrom A-C, Okret S, et al. Mapping of glucocorticoid receptor immunoreactive neurons in the rat tel-and diencephalon using a monoclonal antibody against rat liver glucocorticoid receptor. Endocrinology 1985; 117: 1803–12.PubMedCrossRefGoogle Scholar
  14. 14.
    Agnati LF, Fuxe K, Yu ZY, et al. Morphometrical analysis of the distribution of corticotropin releasing factor, glucocorticoid receptor and phenylethanolamine-n-methyltransferase immunoreactive neurons in the paraventricular hypothalamic nucleus of the rat. Neurosci Lett 1985; 54: 147–52.PubMedCrossRefGoogle Scholar
  15. 15.
    Fuxe K, Harfstrand A, Agnati LF, et al. Immunocytochemical studies on the localization of glucocorticoid receptor immunoreactive nerve cells in the lower brain stem and spinal cord of the male rat using a monoclonal antibody against rat liver glucocorticoid receptor. Neurosci Lett 1985; 60: 1–6.PubMedCrossRefGoogle Scholar
  16. 16.
    Okret S, Wikstrom A-C, Wrange O, Andersson B, Gustafsson J-A. Monoclonal antibodies against the rat liver glucocorticoid receptor. Proc Natl Acad Sci USA 1984; 81: 1609–13.PubMedCrossRefGoogle Scholar
  17. 17.
    Wikstrom A-C, Bakke O, Okret S, Bronnegard M, Gustafsson J-A. Intracellular localization of the glucocorticoid receptor: evidence for cytoplasmic and nuclear localization. Endocrinology 1987; 120: 1232–42.PubMedCrossRefGoogle Scholar
  18. 18.
    Schmidt TJ, Barnett CA, Litwack G. Activation of the glucocorticoidreceptor complex. J Cell Biochem 1982; 20: 15–27.PubMedCrossRefGoogle Scholar
  19. 19.
    Denis M, Wikstrom A-C, Gustafsson J-A. The molybdate-stabilized non-activated glucocorticoid receptor contains a dimer of M 90,000 non-hormone binding protein. J Biol Chem 1987; 262 (in press.Google Scholar
  20. 20.
    Wrange O, Carlstedt-Duke J, Gustafsson J-A. Purification of the glucocorticoid receptor from rat liver cytosol. J Biol Chem 1979; 254: 9284–90.PubMedGoogle Scholar
  21. 21.
    Wrange O, Carlstedt-Duke J, Gustafsson J-A. Stoichiometric analysis of the specific interaction of the glucocorticoid receptor with DNA. J Biol Chem 1986; 261: 11770–8.PubMedGoogle Scholar
  22. 22.
    Carlstedt-Duke J, Gustafsson J-A, Wrange O. Formation and characteristics of hepatic dexamethasone-receptor complexes of different molecular weight. Biochim Biophys Acta 1977; 497: 507–24.PubMedCrossRefGoogle Scholar
  23. 23.
    Wrange O, Gustafsson J-A. Separation of the hormone-and DNA-binding sites of the hepatic glucocorticoid receptor by means of proteolysis. J Biol Chem 1978; 253: 856–65.PubMedGoogle Scholar
  24. 24.
    Carlstedt-Duke J, Okret S, Wrange O, Gustafsson J-A. Immunochemical analysis of the glucocorticoid receptor: identification of a third domain separate from the steroid-binding and DNA-binding domains. Proc Natl Acad Sci USA 1982; 79: 4260–4.PubMedCrossRefGoogle Scholar
  25. 25.
    Wrange O, Okret S, Radojcic M, Carlstedt-Duke J, Gustafsson J-A. Characterization of the purified activated glucocorticoid receptor from rat liver cytosol. J Biol Chem 1984; 259: 4534–41.PubMedGoogle Scholar
  26. 26.
    Carlstedt-Duke J, Stromstedt P-E, Wrange O, Bergman T, Gustafsson J-A, Jornvall H. Domain structure of the glucocorticoid receptor protein. Proc Natl Acad Sci USA 1987; 84: 4437–40.PubMedCrossRefGoogle Scholar
  27. 27.
    Yamamoto KR, Stampfer MR, Tomkins GM. Receptors from glucocorticoid-sensitive lymphoma cells and two classes of insensitive clones: physical and DNA-binding properties. Proc Natl Acad Sci USA 1974; 71: 3901–5.PubMedCrossRefGoogle Scholar
  28. 28.
    Sibley CH, Yamamoto KR. Mouse lymphoma cells: mechanism of resistance to glucocorticoids. In: Baxter JD, Rousseau GG, eds. Glucocorticoid hormone action. Heidelberg: Springer-Verlag, 1979: 357–76.CrossRefGoogle Scholar
  29. 29.
    Northrop JP, Gametchu B, Harrison RW, Ringold GM. Characterization of wild type and mutant glucocorticoid receptors from rat hepatoma and mouse lymphoma cells. J Biol Chem 1985; 260: 6398–403.PubMedGoogle Scholar
  30. 30.
    Gehring U, Tomkins GM. A new mechanism for steroid unresponsiveness: loss of nuclear binding activity of a steroid hormone receptor. Cell 1974; 3: 301–6.PubMedCrossRefGoogle Scholar
  31. 31.
    Dellweg H-G, Hotz A, Mugele K, Gehring U. Active domains in wild-type and mutant glucocorticoid receptors. EMBO J 1982; 1: 285–9.PubMedGoogle Scholar
  32. 32.
    Gehring U, Holz A. Photoaffinity labeling and partial proteolysis of wild-type and variant glucocorticoid receptors. Biochemistry 1983; 22: 4013–8.PubMedCrossRefGoogle Scholar
  33. 33.
    Westphal HM, Mugele K, Beato M, Gehring U. Immunochemical characterization of wild-type and variant glucocorticoid receptors by monoclonal antibodies. EMBO J 1984; 3: 1493–8.PubMedGoogle Scholar
  34. 34.
    Stevens J, Stevens Y-W. Physicochemical differences between glucocorticoid-binding components from the corticoid-sensitive and -resistant strains of mouse lymphoma P1798. Cancer Res 1979; 39: 4011–21.PubMedGoogle Scholar
  35. 35.
    Stevens J, Stevens Y-W, Rhodes J, Steiner G. Differences in nuclear glucocorticoid binding between corticoid-sensitive and corticoid-resistant lymphocytes of mouse lymphoma P1798 and stabilization of nuclear hormone receptor complexes with carbobenzoxy-L-phenylalanine. J Natl Cancer Inst 1978; 61:1477–85.PubMedGoogle Scholar
  36. 36.
    Stevens J, Stevens Y-W. Influence of limited proteolysis on the physicochemical and DNA-binding properties of glucocorticoid receptors from corticoid-sensitive and -resistant mouse lymphoma P1798. Cancer Res 1981; 41: 125–33.PubMedGoogle Scholar
  37. 37.
    Okret S, Stevens Y-W, Carlstedt-Duke J, Wrange O, Gustafsson J-A, Stevens J. Absence in glucocorticoid-resistant mouse lymphoma P1798 of a glucocorticoid receptor domain responsible for biological effects. Cancer Res 1983; 43: 3127–31.PubMedGoogle Scholar
  38. 38.
    Bronnegard M, Werner S, Gustafsson J-A. Primary cortisol resistance associated with a thermolabile glucocorticoid receptor in a patient with fatigue as the only symptom. J Clin Invest 1986; 78: 1270–8.PubMedCrossRefGoogle Scholar
  39. 39.
    Griffin JE, Durrant JL. Qualitative receptor defects in families with androgen resistance: failure of stabilization of the fibroblast cytosol androgen receptor. J Clin Endocrinol Metab 1982; 55: 465–74.PubMedCrossRefGoogle Scholar
  40. 40.
    Kovacs WJ, Griffin JE, Weaver DD, Carlson BR, Wilson JD. A mutation that causes lability of the androgen receptor under conditions that normally promote transformation to the DNA-binding state. J Clin Invest 1984; 73: 1095–104.PubMedCrossRefGoogle Scholar
  41. 41.
    Miesfeld R, Rusconi S, Godowski PJ, et al. Genetic complementation of a glucocorticoid receptor deficiency by expression of cloned receptor cDNA. Cell 1986; 46: 389–99.PubMedCrossRefGoogle Scholar
  42. 42.
    Hollenberg SM, Weinberger C, Ong ES, et al. Primary structure and expression of a functional human glucocorticoid receptor cDNA. Nature 1985; 318: 635–41.PubMedCrossRefGoogle Scholar
  43. 43.
    Danielsen M, Norhrop JP, Ringold GM. The mouse glucocorticoid receptor: mapping of functional domains by cloning, sequencing and expression of wild-type and mutant receptor proteins. EMBO J 1986; 5: 2513–22.PubMedGoogle Scholar
  44. 44.
    Rusconi S, Yamamoto KR. Functional dissection of the hormone and DNA binding activities of the glucocorticoid receptor. EMBO J 1987; 6: 1309–15.PubMedGoogle Scholar
  45. 45.
    Carlstedt-Duke J, Stromstedt P-E, Persson B, Cederlund E, Gustafsson J-A, Jornvall H. Identification of hormone-interacting amino acid residues within the steroid-binding domain of the glucocorticoid receptor in relation to other hormone receptors. EMBO J (submitted for publication).Google Scholar
  46. 46.
    Giguere V, Hollenberg SM, Rosenfeld MG, Evans RM. Functional domains of the human glucocorticoid receptor. Cell 1986; 46: 645–52.PubMedCrossRefGoogle Scholar
  47. 47.
    Hollenberg SM, Giguere V, Segui P, Evans RM. Colocalization of DNA-binding and transcriptional activation functions in the human glucocorticoid receptor. Cell 1987; 49: 39–46.PubMedCrossRefGoogle Scholar
  48. 48.
    Berg JM. Potential metal-binding domains in nucleic acid binding proteins. Science 1986; 232: 485–7.PubMedCrossRefGoogle Scholar
  49. 49.
    Miller J, McLachlan AD, Klug A. Repetitive Zinc-binding domains in the protein transcription factor IIIA from Xenopus oocytes. EMBO J 1985; 4: 1609–14.PubMedGoogle Scholar
  50. 50.
    Miesfeld R, Godowski PJ, Maler BA, Yamamoto KR. Glucocorticoid receptor mutants that define a small region sufficient for enhancer activation. Science 1987; 236: 423–7.PubMedCrossRefGoogle Scholar
  51. 51.
    Godowski PJ, Rusconi S, Miesfeld R, Yamamoto KR. Glucocorticoid receptor mutants that are constitutive activators of transcriptional enhancement. Nature 1987; 325: 365–8.PubMedCrossRefGoogle Scholar
  52. 52.
    Payvar F, DeFranco D, Firestone GL, et al. Sequence-specific binding of glucocorticoid receptor to MTV DNA at sites within and upstream of the transcribed region. Cell 1983; 35: 381–92.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1988

Authors and Affiliations

  • Jan Carlstedt-Duke
    • 1
  • Ann-Charlotte Wikstrom
    • 1
  • Jan-Ake Gustafsson
    • 1
  1. 1.Department of Medical NutritionKarolinska Institutet Huddinge University Hospital F69HuddingeSweden

Personalised recommendations